Home  >  Products  >  MRPL19 (mitochondrial ribosomal protein L19 ) Blocking Peptide (the C terminal of MRPL19)(100ug)
MRPL19 (mitochondrial ribosomal protein L19 ) Blocking Peptide (the C terminal of MRPL19)(100ug)

MRPL19 (mitochondrial ribosomal protein L19 ) Blocking Peptide (the C terminal of MRPL19)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MRPL19 Antibody (ARP62150_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62150
Size: 100ug
Weight: 33kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein.
Alternative names: KIAA0104; L19mt; MGC20675; MRP-L15; MRP-L19; MRPL15; RLX1; RPML15